Back
4Engineers
Rockwell Automation and Cytiva Launch Platform to Accelerate Digital Transformation for Biopharma Companies
Working across multiple instrument vendors and modalities, Figurate SCADA provides the connectivity needed to enable digital integration to advance modern bioprocessing.
Login to comment
LoginRelated Conversations
-
Rockwell Automation Introduces FactoryTalk ResilientEdge to Enable Autonomous, Scalable Manufacturing Operations
0 Replies
-
Rockwell Automation Launches FactoryTalk Orchestration Software at Automate
0 Replies
-
Rockwell Automation Opens Bologna Customer Experience Center to Accelerate Industrial Innovation Across Europe, Middle East and Africa
0 Replies
-
Rockwell Automation and UWM CSI Expand Collaboration to Shape the Future of Manufacturing in the Region
0 Replies
-
Promation, Rockwell Automation and Pacer Precision Logistics Showcase a Connected, GMP-Compliant Radioisotope Supply Chain at SNMMI 2026
0 Replies
Recent Conversations
-
DLR Group Acquires Science and Technology Design Firm McFarlane Architects
0 Replies
-
WGI Wins IPMI Award for Excellence-Honorable Mention For Jacksonville Transportation Authority U²C Bay Street Innovation Corridor Project
0 Replies
-
Skanska Completes Construction on Los Angeles World Airports Roadways, Utilities & Enabling Project (LAWA RUE)
0 Replies
-
Fish-inspired nanorobots for lithium recovery from seawater
0 Replies
-
Chemists use programmable DNA as ‘molecular glue’ to direct protein crystallization
0 Replies
Your Conversations
-
DLR Group Acquires Science and Technology Design Firm McFarlane Architects
0 Replies
-
WGI Wins IPMI Award for Excellence-Honorable Mention For Jacksonville Transportation Authority U²C Bay Street Innovation Corridor Project
0 Replies
-
Skanska Completes Construction on Los Angeles World Airports Roadways, Utilities & Enabling Project (LAWA RUE)
0 Replies
-
Fish-inspired nanorobots for lithium recovery from seawater
0 Replies
-
Chemists use programmable DNA as ‘molecular glue’ to direct protein crystallization
0 Replies